Multiple Myeloma Clinical Trial

Clinical Trial Finder Multiple Myeloma Trials

Multiparametric Imaging in Multiple Myeloma

See Locations Near You

Summary

Patients with Multiple Myeloma will undergo single timepoint Positron Emission Tomography imaging with intravenously injected C11 Methionine to detect viable lesions.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of Multiple Myeloma with symptomatic bone or soft tissue disease
Eastern Cooperative Oncology Group status 0 to 2
Life expectance >= 12 weeks
Ability to understand and willingness to sign informed consent
Tissue sampling with genotype data planned within 3 months of C11 positron emission tomography (PET) imaging

Exclusion Criteria:

Pregnant or breast feeding
Claustrophobic reactions and unable to lie still on a bed inside the PET scanner for 60 minutes
Research related radiation exposure exceeding 50 millisieverts

Study is for people with:

Multiple Myeloma

Phase:

Phase 1

Estimated Enrollment:

10

Study ID:

NCT02646085

Recruitment Status:

Completed

Sponsor:

Yingbing Wang

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Massachusetts General Hospital
Boston Massachusetts, 02114, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Phase:

Phase 1

Estimated Enrollment:

10

Study ID:

NCT02646085

Recruitment Status:

Completed

Sponsor:


Yingbing Wang

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider